Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Auditor change
Director departure
Appointed director
|
|
LifeMD, Inc. (CVLB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| Simon Roberto (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Alvarez Nicholas P (Chief Acquisition Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.92, valued at
$1.6M
|
|
| 07/13/2023 |
4
| Benathen Marc David (CFO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 125,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $21.2, valued at
$4.2M
Exercised 25,000 restricted stock units
@ $0
Exercised 25,000 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Yecies Eric Harold (General Counsel & CCO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.55, valued at
$1.5M
|
|
| 06/16/2023 |
4
| BHATIA NAVEEN (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 06/15/2023 |
4
| Jindal Piyush (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 06/15/2023 |
4
| Roberts Brad Michael (COO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.5, valued at
$1.5M
|
|
| 06/07/2023 |
4
| Velge Bertrand (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 10,383 shares
@ $2.1651, valued at
$22.5k
Bought 129,117 shares
@ $2.1794, valued at
$281.4k
|
|
| 05/24/2023 |
4
| Schreiber Justin (CEO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 17,664 shares
@ $2.152, valued at
$38k
Bought 32,336 shares
@ $2.06, valued at
$66.6k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| FRIEDEMAN JESSICA (Chief Marketing Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 12/23/2022 |
4
| Walsh Kathleen E (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Granted 37,500 options to buy
@ $2.3, valued at
$86.3k
|
|
| 09/20/2022 |
4
| Jindal Piyush (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Granted 37,500 options to buy
@ $2.52, valued at
$94.5k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Yecies Eric Harold (General Counsel & CCO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 5,000 shares
@ $3.14, valued at
$15.7k
|
|
| 03/11/2022 |
4
| DiTrolio Joseph (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 2,000 shares
@ $3.28, valued at
$6.6k
|
|
| 03/04/2022 |
4
| Alvarez Nicholas P (Chief Acquisition Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Gifted 60,000 shares
@ $0 |
|
| 03/04/2022 |
4
| Schreiber Justin (CEO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Gifted 60,000 shares
@ $0 |
|
| 02/14/2022 |
4
| Mironov Alexander (President) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Exercised (in-or-at-the-money) 22,000 shares
@ $1.75, valued at
$38.5k
|
|
| 02/08/2022 |
4
| STAN MARIA E. (Principal Accounting Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 15,000 restricted stock units
@ $0
Exercised 5,000 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Yecies Eric Harold (General Counsel & CCO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 37,500 restricted stock units
@ $0
Exercised 12,500 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Benathen Marc David (CFO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 75,000 restricted stock units
@ $0
Exercised 25,000 restricted stock units
@ $0 |
|
| 01/06/2022 |
4
| Wijnker Dennis (Chief Technology Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 80,000 options to buy
@ $3.78, valued at
$302.4k
|
|
| 12/08/2021 |
4
| Velge Bertrand (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 25,000 shares
@ $4.54, valued at
$113.5k
|
|
| 12/07/2021 |
4
| Velge Bertrand (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 294,118 shares
@ $0.17, valued at
$50k
Granted 173,234 shares
@ $0
Bought 96,923 shares
@ $0.65, valued at
$63k
Bought 110,000 shares
@ $3.91, valued at
$430.1k
Granted 2,500 options to buy
@ $1.15, valued at
$2.9k
Granted 2,500 options to buy
@ $1.15, valued at
$2.9k
Granted 2,500 options to buy
@ $1.2, valued at
$3k
Granted 2,500 options to buy
@ $1.5, valued at
$3.8k
Granted 100,000 options to buy
@ $4.65, valued at
$465k
Granted 2,500 options to buy
@ $7.95, valued at
$19.9k
Granted 2,500 options to buy
@ $7, valued at
$17.5k
|
|
| 12/01/2021 |
4
| BHATIA NAVEEN (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 50,000 shares
@ $4.2633, valued at
$213.2k
|
|
| 12/01/2021 |
4
| Benathen Marc David (CFO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 7,831 shares
@ $4.09, valued at
$32k
|
|
| 11/30/2021 |
4
| BHATIA NAVEEN (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 50,000 shares
@ $3.876, valued at
$193.8k
|
|
| 11/23/2021 |
4
| Yecies Eric Harold (CCO and General Counsel) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 7,400 shares
@ $4.12, valued at
$30.5k
|
|
| 11/22/2021 |
4
| DiTrolio Joseph (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 2,000 shares
@ $4.89, valued at
$9.8k
|
|
| 11/18/2021 |
4
| Galluppi Stefan (Chief Technology Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 100 shares
@ $4.79, valued at
$479
Bought 1,206 shares
@ $4.8, valued at
$5.8k
Bought 542 shares
@ $4.81, valued at
$2.6k
|
|
| 11/16/2021 |
4
| Galluppi Stefan (Chief Technology Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 2,097 shares
@ $4.55, valued at
$9.5k
Bought 100 shares
@ $4.54, valued at
$454 |
|
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|